Who Paid My Doc
Mary Stewart
Hematology & Oncology Anchorage, AK Medical Doctor
NPI 1245268002 CMS profile 146892
2925 Debarr Rd, Suite 300, Anchorage, AK 99508
General payments
$9,310
Research payments
$0
Ownership & investment interest
$0
Through program year 2023, Mary Stewart of Anchorage, AK is reported in the CMS Open Payments database as having received $9,310 across 386 general payments and $0 in research payments paid to them.
No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.
General payments for this record sit in the 70th percentile of Hematology & Oncology profiles with reported payments. Percentile describes the distribution, not the conduct.
By program year
5 rows| Year | Kind | Relative to this record's peak year | Amount | Records |
|---|---|---|---|---|
| 2023 | General | $1,424 | 55 | |
| 2022 | General | $1,971 | 82 | |
| 2021 | General | $1,828 | 85 | |
| 2020 | General | $1,125 | 54 | |
| 2019 | General | $2,962 | 110 |
Beside peers
- Mary Stewart
- Hematology & Oncology median
- Middle half of Hematology & Oncology
- National median
In program year 2025, general payments to Mary Stewart were reported at $0. Among 8,769 Hematology & Oncology profiles paid that year, the median was $683 and the middle half received between $143 and $3,154.
Show as a table
| Year | Mary Stewart | Hematology & Oncology median | Middle half | National median |
|---|---|---|---|---|
| 2019 | $2,962 | $529 | $121–$2,516 | $163 |
| 2020 | $1,125 | $339 | $82–$2,213 | $114 |
| 2021 | $1,828 | $263 | $49–$1,965 | $132 |
| 2022 | $1,971 | $416 | $103–$2,395 | $149 |
| 2023 | $1,424 | $542 | $125–$2,646 | $160 |
| 2024 | $0 | $692 | $141–$3,008 | $164 |
| 2025 | $0 | $683 | $143–$3,154 | $169 |
Breakdown
A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.
Records
386 reportedEvery payment, record by record
Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.
Other Hematology & Oncology in Alaska
Steven Liu
Hematology & Oncology · Anchorage, AK
David Eilender
Hematology & Oncology · Soldotna, AK
Max Rabinowitz
Hematology & Oncology · Anchorage, AK
Mary Klix
Hematology & Oncology · Anchorage, AK
Kendal Webb
Hematology & Oncology · Anchorage, AK
Natalie Wallace
Hematology & Oncology · Anchorage, AK
Related records
Hematology & Oncology in Alaska
Practitioners in the same specialty and state, ranked by reported value.
All Hematology & Oncology
Everyone recorded under this specialty, nationwide.
Doctors in Alaska
Every practitioner in the state with a reported payment.
How to read this page
What each amount means, and what it does not mean.
What this means
U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.
An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.
Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.